Full-Time

Vice President – Brand

Weight Watchers

Weight Watchers

5,001-10,000 employees

Group-based weight loss program with meetings

Compensation Overview

$250k - $275k/yr

+ Annual Bonus Program

New York, NY, USA

Hybrid

Hybrid work environment; some on-site presence may be required.

Category
UI/UX & Design (1)
Required Skills
Branding/Brand Strategy
Data Analysis

Get referred to Weight Watchers

See people who can refer or advise you

Requirements
  • 15+ years of Brand Leadership: Significant experience in brand strategy and architecture for an agency or start-up.
  • The Magician Profile: Proven track record as a visionary who knows how to partner with high-level creatives to achieve excellence without being in the weeds of production.
  • Executive Gravitas: Deep experience in stakeholder management; comfortable providing pushback to C-Suite and senior leaders to protect the brand and the team.
  • Architect Mindset: You are a master of frameworks, positioning, and organizational flow. You see around corners and identify gaps before they become chaos.
  • Strategic Resilience: Comfortable operating as a partner and translating big-level ideas into a usable roadmap for a fast-paced team.
  • People-First Leader: Experience leading "leaders"—knowing how to empower established heads of Content, Social, Creative and Opps rather than replacing their influence.
Responsibilities
  • Own the Foundation: Evolve the brand strategy, including architecture, global positioning, and the transition into new clinical/health pathways (e.g., GLP-1) while supporting our historic core offerings and overall customer experience.
  • Codify the Playbook: Create the frameworks and guardrails that allow the execution teams to scale without brand dilution.
  • The "Glue": Ensure the brand voice is cohesive across Marketing, Product, UX, and Operations, acting as the connective tissue between departments.
  • Protect the Runway: Serve as the primary advocate for the brand at the leadership level. Manage up and out to align stakeholders and provide healthy pushback against chaos or shifting whims.
  • Strategic Buffering: Act as the filter for high-level ambiguity into clear, actionable directives for the brand team.
  • Organizational Authority: Navigate complex cross-functional webs to embed brand thinking into every decision, ensuring the brand team isn't caught in the weeds of complexity.
  • Support, Don’t Execute: Partner closely with the Creative Director, Head of Content, Head of Ops and Head of Brand Social to translate high-level strategy into compelling work with measurable results.
  • The Visionary Partner: Provide the "Strategic Why" that informs creative briefs. You are a "creatively-minded magician" who knows how to get the best out of experts without trying to do their jobs or micromanage their output.
  • Champion the Work: Use your seat at the VP table to champion the brand and creative vision and defend the integrity of the output.
  • Insights to Action: Lead the deep understanding of the customer—behaviors, motivations, and cultural context—and translate these into actionable brand platforms for the creative teams.
  • Brand Health: Partner with cross-functional teams to monitor perception and sentiment, using data to justify brand investments and long-term equity to the executive team.
  • Balance Performance & Pulse: Connect brand strategy to growth goals (acquisition, retention) without sacrificing the creative impact or cultural relevance.

Weight Watchers runs a weight management program centered on group support and accountability. Members join meetings for guidance, share tips, and track progress as part of a community that helps people manage eating and activity habits rather than promoting a single diet. The program typically involves paying a weekly or regular fee for in-person or virtual meetings, plus related products and materials that support behavior change. It differentiates itself from competitors by emphasizing a social, ongoing support system and a structured points-based approach to eating that members follow within a community framework, rather than relying on short-term diet plans. The company’s goal is to help people achieve healthier weight and lifestyles through long-term, sustainable changes supported by a network of peers and coaches.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

New York City, New York

Founded

1963

Get referred to Weight Watchers

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 clinical revenue rose 30.4% to $39.9 million, accelerating mix shift.
  • August 2026 results reaffirmed $620–635 million revenue and $105–115 million EBITDA guidance.
  • Debt dropped to $465 million after June 2025 Chapter 11, sharply lowering interest burden.

What critics are saying

  • Q2 2026 behavioral subscribers fell 24.6% to 2.29 million, crushing the legacy business.
  • Tara Comonte resigned March 31, 2026, leaving Felicia DellaFortuna and Jonathan Volkmann interim control.
  • FDA and Novo Nordisk compounding crackdowns can erase the clinical growth engine by 2027.

What makes Weight Watchers unique

  • WW’s clinical-plus-behavioral model pairs board-certified clinicians with the decades-old meetings brand.
  • Core+ reached 541,000 subscribers in Q2 2026, proving premium tier demand.
  • WeightWatchers still owns a recognizable trust brand built since 1963.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Flexible Work Hours

Hybrid Work Options

Company News

Yahoo Finance
Aug 19th, 2026
WeightWatchers revenue drops 14% to $162M as consumer discretionary stocks decline

WeightWatchers reported Q2 revenues of $162.3 million, down 14.2% year-on-year but exceeding analyst expectations by 2%. The wellness company beat EPS estimates but missed EBITDA projections in what was deemed a satisfactory quarter. Despite the relatively good results, WeightWatchers delivered the weakest full-year guidance update among nine consumer discretionary specialised consumer services stocks tracked. The sector as a whole underperformed in Q2, with revenues missing consensus estimates by 0.7%. The market reacted negatively to WeightWatchers' outlook. Shares fell 8.4% following the earnings announcement and currently trade at $14.12. Consumer discretionary specialised consumer services stocks have declined 4.6% on average since their latest earnings results.

Yahoo Finance
Aug 14th, 2026
WeightWatchers beats revenue estimates despite 14% decline, shifts focus to clinical weight loss tiers

WeightWatchers reported second-quarter revenue of $162.3 million, beating analyst estimates of $159.1 million despite a 14.2% year-on-year decline. The company posted earnings per share of $1.41, significantly above the $0.67 estimate. Management highlighted a strategic shift towards higher-value membership tiers and clinical offerings, with growth in Core+ and Med+ subscribers offsetting declines in traditional behavioural segments. Interim Chief Operations Officer Jonathan Volkmann noted the company's approach combines FDA-approved GLP-1 medications with expert guidance. The company reaffirmed full-year revenue guidance of $627.5 million and EBITDA guidance of $110 million. Operating margin fell to 8.1% from 28.1% in the prior year quarter. No analyst question-and-answer session occurred during the earnings call.

Yahoo Finance
Aug 6th, 2026
WW International reports $162M Q2 revenue as clinical subscribers surge 55.7% and debt falls 70%

WW International reported Q2 2026 revenue of $162.3 million, down from $189.2 million the previous year. Clinical subscription revenue grew 30.4% year-over-year to $39.9 million, now representing 24.6% of total revenue. Clinical subscribers reached 197,000, up 55.7% annually. The company's Core+ tier showed momentum with 541,000 subscribers, up 13.9% year-over-year, marking three consecutive quarters of sequential growth. However, total subscribers fell 24.6% to 2.3 million due to weakness in the Core tier. WW reported net income of $14.1 million and adjusted EBITDA of $39.8 million with a 24.5% margin. The company generated $24.3 million in operating cash flow and reduced its term loan to $423.6 million, down over 70% from $1.6 billion before reorganisation. Management reaffirmed full-year 2026 guidance of $620-635 million in revenue and $105-115 million adjusted EBITDA.

Yahoo Finance
Aug 5th, 2026
WeightWatchers beats Q2 revenue expectations despite 14.2% year-on-year decline to $162.3M

WeightWatchers reported second quarter revenue of $162.3 million, beating analyst estimates of $159.1 million but falling 14.2% year-on-year. The personal wellness company posted GAAP earnings of $1.41 per share, significantly exceeding the $0.67 consensus estimate. The company maintained its full-year revenue guidance of $627.5 million at the midpoint, which came in 0.7% below analyst expectations. EBITDA guidance of $110 million surpassed estimates of $107.9 million. Operating margin declined to 5.8% from 32.3% in the prior-year quarter. Free cash flow improved to $30.06 million, up from negative $38 million year-on-year. WeightWatchers has struggled with declining demand, with revenue falling at a 12.4% annual rate over the past five years. Analysts forecast revenue will decline 6.2% over the next 12 months.

Yahoo Finance
Aug 4th, 2026
WeightWatchers Q2 earnings: revenue expected to decline 15.9% year on year

WeightWatchers will report its second-quarter earnings on Wednesday after market close. The market expects the company's revenue to decline 15.9% year on year, a further deceleration from the 6.4% decrease it recorded in the same quarter last year. In the first quarter, WeightWatchers beat revenue expectations with $168.3 million, down 9.8% year on year. However, the company significantly missed analysts' EBITDA and EPS estimates. Analysts covering WeightWatchers have generally reconfirmed their estimates over the last 30 days. The company has missed Wall Street's revenue estimates multiple times over the last two years. Shares are currently trading at $16.05, below the average analyst price target of $28.33.